Pyridostigmine Bromide
- Product NDC
- 62559-470
- 11-digit product format
- 625590470
- Labeler code
- 62559
- Product ID
- 62559-470_138c3e38-dc2d-46be-8ee6-bef9221a971c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA040512
- Marketing category
- ANDA
- Marketing start
- 2024-01-16
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 60 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903857 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62559-470-01 | Pyridostigmine Bromide | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62559-470 | PYRIDOSTIGMINE BROMIDE TABLET [ANI PHARMACEUTICALS, INC.] | 2 | Current NDC, 1 package rows | 20240117_0a114d99-e50b-49fe-9e0f-ccce279ffb4f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62559-470-01 | 62559047001 | 100 TABLET in 1 BOTTLE (62559-470-01) | 100 tablet | 2024-01-16 | No | No | Historical |